IP Library Assignment 042785/0401
Patent Assignment
Reel/Frame 042785/0401

Assignment of Assignor's Interest

Recorded: 2017-06-22 Pages: 8
Assignor
REMEDY PHARMACEUTCALS, INC.
Executed: 2017-05-12
Assignee
BIOGEN CHESAPEAKE LLC
225 BINNEY STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (16)
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non Selective Ca Activated ATP- Sensitive Cation Channels Regulated by SUR1 Receptors
Application: 12/444,908 →
Publication: US 2010/0056444
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Patent: 8,277,845 →
Application: 12/746,164 →
Publication: US 2010/0273886
Liquid Formulations of Compounds Active at Sulfonylurea Receptors
Application: 12/863,525 →
Publication: US 2011/0034560
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Patent: 8,858,997 →
Application: 13/610,335 →
Publication: US 2013/0245069
Treatment of Alzheimer's Disease Using Compounds that Reduce the Activity of Non-Selective CA++ Activated ATP-Sensitive Cation Channels Regulatd by SUR1 Channels
Application: 13/779,511 →
Publication: US 2014/0080811
Methods of Intravenous Administration of Glyburide and Other Drugs
Patent: 8,946,293 →
Application: 13/811,037 →
Publication: US 2013/0203853
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Application: 14/508,488 →
Publication: US 2015/0141516
Methods of Intravenous Administration of Glyburide
Patent: 9,254,259 →
Application: 14/525,992 →
Publication: US 2015/0157560
Methods of Intravenous Administration of Glyburide
Patent: 9,561,176 →
Application: 14/878,232 →
Publication: US 2016/0030370
Liquid Formulations of Compounds Active at Sulfonylurea Receptors
Application: 15/094,461 →
Publication: US 2017/0216321
Methods of Intravenous Administration of Glyburide
Application: 15/422,358 →
Methods of Intravenous Administration of Glyburide
Application: 15/425,874 →
Publication: US 2017/0333340
Treatment of Alzheimer's disease using sulfonylureas or other compounds that either affect SUR1 receptors or pores associated with channels regulated by SUR1 receptors
Application: 60/851,412 →
Formulations and Methods for Lyophilization and Lyophilates Provided Thereby
Application: 60/992,241 →
Liquid Formulations of Compounds Active at Sulfonylurea Receptors
Application: 61/024,499 →
Methods of Intravenous Administration of Glyburide and other Drugs
Application: 61/365,689 →
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 13, 2008
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 021378/0838 →
Assignment of Assignor's Interest Nov 11, 2008
From: JACOBSON, SVEN; CLARKE, GILLIAN; MATHARU, RAJINDER
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 021816/0329 →
Assignment of Assignor's Interest Nov 12, 2008
From: JACOBSON, SVEN; ANG, ROBERT
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 021822/0613 →
Assignment of Assignor's Interest Sep 9, 2010
From: JACOBSON, SVEN MARTIN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 024963/0556 →
Assignment of Assignor's Interest Mar 21, 2013
From: JACOBSON, SVEN MARTIN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 030063/0786 →
Assignment of Assignor's Interest Jun 10, 2013
From: JACOBSON, SVEN; ANG, ROBERT
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 030580/0274 →
Assignment of Assignor's Interest Dec 6, 2013
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 031731/0240 →
Assignment of Assignor's Interest Dec 17, 2013
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 031799/0107 →
Assignment of Assignor's Interest Sep 8, 2014
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 033690/0498 →
Assignment of Assignor's Interest Dec 10, 2014
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 034454/0263 →
Assignment of Assignor's Interest Jan 7, 2015
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 034653/0273 →
Assignment of Assignor's Interest Oct 8, 2015
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 036756/0954 →
Assignment of Assignor's Interest Aug 23, 2023
From: BIOGEN CHESAPEAKE LLC
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 064678/0502 →